Callan Capital, LLC Genmab A/S Transaction History
Callan Capital, LLC
- $1.35 Billion
- Q1 2025
A detailed history of Callan Capital, LLC transactions in Genmab A/S stock. As of the latest transaction made, Callan Capital, LLC holds 14,361 shares of GMAB stock, worth $303,735. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,361Holding current value
$303,735% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
251Shares Held
61.5MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$316 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$107 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$65.4 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$59.5 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$59.3 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.9B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...